News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,417 Results
Type
Article (1754)
Company Profile (10)
Press Release (71653)
Section
Business (30966)
Career Advice (50)
Deals (5484)
Drug Delivery (6)
Drug Development (8255)
Employer Resources (6)
FDA (1415)
Job Trends (1876)
News (43858)
Policy (2492)
Tag
Academia (128)
Accelerated approval (3)
Allergies (18)
Alliances (2372)
ALS (9)
Alzheimer's disease (157)
Antibody-drug conjugate (ADC) (42)
Approvals (1496)
Artificial intelligence (36)
Autoimmune disease (15)
Automation (2)
Bankruptcy (16)
Best Places to Work (1824)
BIOSECURE Act (1)
Biosimilars (13)
Biotechnology (9)
Bladder cancer (46)
Brain cancer (3)
Breast cancer (105)
Cancer (669)
Cardiovascular disease (41)
Career advice (51)
Career pathing (6)
CAR-T (13)
CDC (2)
Cell therapy (45)
Cervical cancer (3)
Clinical research (7745)
Collaboration (85)
Compensation (1120)
Complete response letters (2)
COVID-19 (253)
CRISPR (5)
C-suite (60)
Cystic fibrosis (18)
Data (929)
Depression (14)
Diabetes (58)
Diagnostics (797)
Digital health (6)
Diversity, equity & inclusion (2)
Drug discovery (11)
Drug pricing (10)
Duchenne muscular dystrophy (8)
Earnings (27867)
Editorial (4)
Employer branding (2)
Employer resources (6)
Events (7145)
Executive appointments (73)
FDA (1910)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (6)
Funding (58)
Gene editing (10)
Generative AI (2)
Gene therapy (33)
GLP-1 (99)
Government (305)
Guidances (257)
Healthcare (2831)
HIV (1)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (28)
Immuno-oncology (5)
Indications (18)
Infectious disease (265)
Inflammatory bowel disease (31)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (12)
Interviews (4)
IPO (4472)
IRA (5)
Job creations (149)
Job search strategy (41)
JPM (1)
Kidney cancer (5)
Labor market (17)
Layoffs (35)
Legal (361)
Liver cancer (7)
Longevity (2)
Lung cancer (122)
Lymphoma (73)
Machine learning (2)
Management (1)
Manufacturing (31)
MASH (26)
Medical device (1830)
Medtech (1836)
Mergers & acquisitions (1160)
Metabolic disorders (151)
Multiple sclerosis (27)
NASH (2)
Neurodegenerative disease (22)
Neuropsychiatric disorders (13)
Neuroscience (275)
NextGen: Class of 2026 (707)
Non-profit (177)
Now hiring (3)
Obesity (68)
Opinion (6)
Ovarian cancer (18)
Pain (15)
Pancreatic cancer (24)
Parkinson's disease (18)
Partnered (2)
Patents (22)
Patient recruitment (29)
Peanut (10)
People (3030)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase 1 (1829)
Phase 2 (3002)
Phase 3 (3458)
Pipeline (1397)
Policy (9)
Postmarket research (284)
Preclinical (537)
Press Release (2)
Prostate cancer (16)
Psychedelics (1)
Radiopharmaceuticals (20)
Rare diseases (61)
Real estate (253)
Recruiting (4)
Regulatory (2196)
Reports (12)
Research institute (117)
Resumes & cover letters (4)
Rett syndrome (1)
RNA editing (1)
RSV (7)
Schizophrenia (22)
Series A (2)
Series B (2)
Sickle cell disease (11)
Special edition (3)
Spinal muscular atrophy (20)
Sponsored (2)
Startups (103)
Stomach cancer (1)
Supply chain (3)
Tariffs (2)
The Weekly (1)
Vaccines (62)
Venture capital (5)
Weight loss (38)
Women's health (7)
Worklife (3)
Date
Today (22)
Last 7 days (92)
Last 30 days (253)
Last 365 days (4876)
2026 (359)
2025 (4955)
2024 (5535)
2023 (6105)
2022 (7110)
2021 (7505)
2020 (6810)
2019 (5010)
2018 (3741)
2017 (3237)
2016 (2213)
2015 (3031)
2014 (2544)
2013 (1388)
2012 (1559)
2011 (1691)
2010 (1588)
Location
Africa (47)
Alabama (8)
Arizona (21)
Asia (3896)
Australia (464)
California (1963)
Canada (423)
China (115)
Colorado (82)
Connecticut (77)
Delaware (91)
Europe (10296)
Florida (299)
Georgia (40)
Idaho (3)
Illinois (97)
India (5)
Indiana (84)
Japan (66)
Kansas (7)
Kentucky (7)
Louisiana (8)
Maine (15)
Maryland (170)
Massachusetts (1376)
Michigan (37)
Minnesota (70)
Mississippi (1)
Missouri (16)
Montana (4)
Nevada (18)
New Hampshire (9)
New Jersey (560)
New York (462)
North Carolina (226)
Northern California (1051)
Ohio (47)
Oklahoma (1)
Oregon (2)
Pennsylvania (352)
Rhode Island (2)
South America (89)
South Carolina (2)
Southern California (775)
Tennessee (26)
Texas (265)
United States (6484)
Utah (57)
Virginia (13)
Washington D.C. (17)
Washington State (142)
West Virginia (2)
Wisconsin (8)
73,417 Results for "56".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aprea Therapeutics Announces $5.6 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 29, 2026
·
5 min read
Press Releases
Proton Pump Inhibitors Market Outlook 2025–2032: Strong CAGR of 5.6% with USD 5.90 Billion Valuation
November 3, 2025
·
1 min read
Press Releases
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
November 20, 2025
·
10 min read
Press Releases
CUTISS closes CHF 56M Series C round and signs agreement with leading EU burn center
September 10, 2025
·
2 min read
FDA
6 FDA Decisions To Watch in Q1 2026
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after being delayed from the fourth quarter last year.
January 12, 2026
·
8 min read
·
Tristan Manalac
Press Releases
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy
September 22, 2025
·
9 min read
Press Releases
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
June 4, 2025
·
4 min read
Biotech Bay
Attralus Closes $56 Million Financing
Attralus, Inc., a clinical-stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, announced that it has closed a $56 million financing.
February 6, 2024
·
7 min read
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced its participation in the Jefferies Healthcare Conference in New York on June 5-6, 2024.
May 29, 2024
·
2 min read
Press Releases
Immunoassay Market Size Expected to Hit USD 56.20 Billion by 2034
February 20, 2025
·
1 min read
1 of 7,342
Next
